Navigation Links
Optimer Pharmaceuticals Appoints Gregory Papaz to New Position of Senior Vice President of Commercial Operations
Date:12/20/2010

SAN DIEGO, Dec. 20, 2010 /PRNewswire-FirstCall/ -- Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR) today announced that Gregory Papaz has joined Optimer as Senior Vice President of Commercial Operations.  Mr. Papaz will lead the preparations for the planned commercialization of fidaxomicin.  He brings with him more than thirty years of experience in the healthcare and pharmaceutical industry managing pharmaceutical sales teams.

(Logo:  http://photos.prnewswire.com/prnh/20090413/LA97352LOGO)

"Greg comes to Optimer with best-in-class business experience in the hospital and specialty market segments combined with a proven record of recent successful new product introductions," said Pedro Lichtinger, Optimer's President and CEO. "Greg will build and lead our commercial organization in the United States and is ideally suited to lead a successful hospital launch for fidaxomicin."

Prior to joining Optimer, Mr. Papaz held the position of Rheumatology Sales Director, Commercial Marketing at Genentech where he was responsible for planning and launching Actemra®, a drug for rheumatoid arthritis. In this role, Mr. Papaz staffed a 130-person sales team which sold directly into hospitals, with direct contact to hospital pharmacies, physician leaders and hospital management. Prior to Genentech, he worked for Roche Pharma as the Anemia National Sales Director. Prior to Roche Pharma, Mr. Papaz was the Vice President, Cardiovascular Hospital Sales at Sanofi-Aventis.  While in this position, Greg merged and restructured the Sanofi hospital team with the Aventis Advanced Therapeutics team.  This resulted in the creation of the largest specialized sales force at Sanofi, as well as the largest hospital sales force in the U.S. pharma industry.  Consequently, Greg was involved in overs
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Optimer Pharmaceuticals to Host Investor and Analyst Event on November 18
2. Optimer Pharmaceuticals Announces Combined Data From Fidaxomicin Phase 3 Trials for the Treatment of Clostridium difficile Infection (CDI) Presented at IDSA
3. Optimer Pharmaceuticals Announces Presentations of Additional Fidaxomicin Phase 3 Data at Upcoming ICAAC Annual Meeting
4. Optimer Pharmaceuticals to Present at September 2010 Investor Conferences
5. Optimer Pharmaceuticals Fidaxomicin Marketing Authorization Application Accepted for Review by European Medicines Agency
6. Optimer Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference
7. Optimer Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference
8. Optimer Announces Presentation of Additional Data From Fidaxomicin Phase 3 Study for the Treatment of Clostridium Difficile Infection (CDI)
9. Data From Optimers Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
10. Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection
11. Optimer Pharmaceuticals Receives Production Patent for Lead Product Candidate Fidaxomicin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... COVENTRY, R.I. , May 22, 2015 /PRNewswire/ ... a once-daily central nervous system stimulant indicated for ... available to patients beginning Summer 2015. ... Aptensio XR received approval from the U.S. Food ... XR is an extended-release formulation of methylphenidate capsule ...
(Date:5/22/2015)... REDWOOD CITY, Calif. , May 22, 2015 /PRNewswire/ ... specialty pharmaceutical company focused on the development and commercialization ... breakthrough pain, today announced that interim chief executive officer ... 2015 Healthcare Conference and chief financial officer Tim ... Science Conference. Details of the two presentations are as ...
(Date:5/21/2015)... , May 21, 2015  When Ryan ... the side of his neck, he figured ... a couple weeks off from weight lifting. ... away.                               A series ... was referred to Michel Kliot, MD ...
Breaking Medicine Technology:Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 2Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 3Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 4Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 5Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 6AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences In June 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 4
(Date:5/24/2015)... Raleigh, NC (PRWEB) May 24, 2015 ... published a paper on air quality compliance issues that ... of American workers. Surviving Mesothelioma has just posted an ... it now. , The group found airborne asbestos ... inspection data collected between 1984 and 2011. , “Asbestos ...
(Date:5/24/2015)... New York (PRWEB) May 24, 2015 ... treatment lawsuits ( http://www.testosteronelawsuithub.com/ ) has scheduled its ... progress of the multidistrict litigation. According to court ... District of Illinois, the Conference will be convened ... re: Testosterone Replacement Therapy Product Liability Litigation - ...
(Date:5/24/2015)... Indiana Fiber Network, LLC (IFN), the leading Indiana ... Inc. (MTA) has selected IFN as a fiber transport ... Sales Manager, fiber route diversity and network redundancy are ... MTA with the diverse fiber transport from their Merrillville ... voice carriers located at Henry Street in Indianapolis, IN. ...
(Date:5/24/2015)... Geneva, WI (PRWEB) May 24, 2015 ... Mercy Health System CEO - ... principal and honored at the fourth ... held April 15 at Geneva National ... (by school): ,     -Badger High School, ...
(Date:5/23/2015)... Florida City, FL (PRWEB) May 23, 2015 ... together to build a new playground for Branches Florida City ... destroyed the former play space in 2010. , A large ... then new playground on May 23, 2010 in the middle ... families watched. The fire was later declared arson even though ...
Breaking Medicine News(10 mins):Health News:New Analysis Finds Too Many Employers Ignored OSHA Asbestos Guidelines, According to Surviving Mesothelioma 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Look Ahead to June Conference in Federal Multidistrict Litigation 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Look Ahead to June Conference in Federal Multidistrict Litigation 3Health News:Indiana Fiber Network, LLC Enables Midwest Telecom of America with Fiber Route Diversity 2Health News:Mercy Foundation Honors 16 Students for Making a Difference - Mercy Health System Javon Bea 2Health News:Five Years After Fire, Branches Rebuilds Playground 2
... for Health announces broad agreement on principles for Getting ... Act WASHINGTON, April 30 Today the Markle Foundation ... to investments in health information technology (IT) under the ... care and information technology will meet with government and ...
... for Pulmonary Fibrosis (CPF) is pleased to announce the airing ... Television (CMT),s CMT Insider show on Saturday, May ... interview was taped at the recent "A Night of Burnin, ... late Dennis Linde in Nashville at the Musician,s Hall of ...
... Biogen Idec (NASDAQ: BIIB) today announced data results from ... (MS) Prevention Study In Ongoing Neurologic Surveillance) study, an ... AVONEX MS Prevention Study). Based on the CHAMPS ... who experienced their first clinical MS episode with MRI ...
... today re-issued a series of It,s Not Flu ... preparedness for families, businesses, medical providers, and community groups."Worry and ... planning ahead will," said Jeff Levi, Ph.D., Executive Director of ... to protect ourselves and our families in the event of ...
... Respond to Increasing Support for Men,s Health Issues ... Men,s Health Network applauds Representatives Barron Hill (D-IN) ... 2115, the "Men and Families Health Care Act ... of Men,s Health within the Department of Health ...
... trachomatis is the most common bacterial agent of ... reported infections in the United States each year. ... (CNSI) at UCLA and the David Geffen School of ... for inducing immunity to the infection. The findings could ...
Cached Medicine News:Health News:Meaningful Investment of $19 Billion on Health Information Technology 2Health News:Meaningful Investment of $19 Billion on Health Information Technology 3Health News:Actor James Marsden To Appear on CMT Insider May 2, Talk About Pulmonary Fibrosis 2Health News:Actor James Marsden To Appear on CMT Insider May 2, Talk About Pulmonary Fibrosis 3Health News:First 10-year follow-up shows that treatment with AVONEX leads to long-term benefits in early multiple sclerosis patients 2Health News:Pandemic Flu Preparedness Guides for Families, Businesses, Medical Providers, and Community Groups Released by Trust for America's Health 2Health News:Pandemic Flu Preparedness Guides for Families, Businesses, Medical Providers, and Community Groups Released by Trust for America's Health 3Health News:Pandemic Flu Preparedness Guides for Families, Businesses, Medical Providers, and Community Groups Released by Trust for America's Health 4Health News:Pandemic Flu Preparedness Guides for Families, Businesses, Medical Providers, and Community Groups Released by Trust for America's Health 5Health News:Pandemic Flu Preparedness Guides for Families, Businesses, Medical Providers, and Community Groups Released by Trust for America's Health 6Health News:U.S. Representatives Hill and Murphy Introduce the 'Men and Families Health Care Act of 2009' 2Health News:Researchers design unique method to induce immunity to certain STDs 2Health News:Researchers design unique method to induce immunity to certain STDs 3
... Used to connect ... an infusion pump, and ... catheter in order to ... use with Laborie Medical ...
Used for suprapubic monitoring of bladder pressures. Suprapubic urodynamic studies avoid the effects of urethral catheterization and eliminate the need for a double bladder puncture. Supplied sterile...
... Cardiac Panel is a fluorescence ... quantitative determination of CK-MB, myoglobin ... acid (EDTA) whole blood and ... used as an aid in ...
... When your patients present with AMI ... essence, RAMP offers a rapid, reliable ... needs. Utilizing unique assay enhancement techniques, ... flow test cartridges, RAMP delivers highly ...
Medicine Products: